about
Delivery systems for bone growth factors - the new players in skeletal regeneration.Controlled delivery systems: from pharmaceuticals to cells and genes.Molecular imprinting science and technology: a survey of the literature for the years 2004-2011.3D PLLA/ibuprofen composite scaffolds obtained by a supercritical fluids assisted process.Agarose gel as biomaterial or scaffold for implantation surgery: characterization, histological and histomorphometric study on soft tissue response.Biodegradable polymers and composites in biomedical applications: from catgut to tissue engineering. Part 2 Systems for temporary replacement and advanced tissue regenerationPerspectives on: Supercritical Fluid Technology for 3D Tissue Engineering Scaffold ApplicationsSupercritical fluids in biomedical and tissue engineering applications: a review
P2860
Q35751776-412901A4-7665-4200-9AB8-2184991513D7Q37855597-DF7E8846-EB1C-4E2F-8C4C-3027F55B71AFQ38202089-6B275987-D290-4967-9EF2-1A8820AF44C4Q44276587-615886DC-A541-4726-AFAE-3AD3A895BF7DQ45903013-4CC7421D-4D65-4B1D-AD84-93376A400926Q57170595-8D166315-55AD-4B60-A66E-808990D6CDB3Q57171625-0099F0BB-A1E4-42D8-ACD0-E727FEB55CF6Q57171638-38910A90-4F6B-476E-9F8C-15DFCE8C3776
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2002
@uk
name
Drug delivery therapies II
@en
Drug delivery therapies II
@nl
type
label
Drug delivery therapies II
@en
Drug delivery therapies II
@nl
prefLabel
Drug delivery therapies II
@en
Drug delivery therapies II
@nl
P2093
P1476
Drug delivery therapies II
@en
P2093
P304
P356
10.1016/S1359-0286(02)00077-3
P577
2002-08-01T00:00:00Z